Quibim
Transforming imaging data into actionable predictions for improved patient outcomes through AI-powered solutions, with a commitment to data security and innovation in Life Sciences.
Quibim is a pioneering AI-powered imaging solutions company for Life Sciences, specializing in the extraction of radiomics drivers from large imaging data registries with a cloud-based, tissue-agnostic platform. They hold ISO27001 certification and ensure data security through encrypted storage and transfer. Quibim partners with Merck KGAA to develop next-generation imaging-based diagnostics for precision medicine and have expanded their reach by adding cancer detection capability to their prostate AI product. Their mission is to transform imaging data into actionable predictions, ultimately improving patient outcomes.
About Quibim
Quibim is a leading company in the field of AI-powered imaging solutions for Life Sciences. They develop pioneering tools that unlock imaging data to improve patient outcomes. Quibim's platform is a cloud-based, tissue-agnostic solution designed to extract key radiomics drivers from large imaging data registries. Their precision-focused approach is driven by their commitment to data security, as evidenced by their ISO27001 certification and encrypted data storage and transfer.
Quibim's partnership with Merck KGAA in Germany is a testament to their innovation in creating next-generation imaging-based diagnostics for precision medicine. Additionally, they have added industry-leading cancer detection capability to their prostate AI product, further expanding their reach in the healthcare sector.
Quibim's mission is to transform imaging data into actionable predictions, ultimately leading to better patient outcomes. Their Culture & Values, Meet the team, and Sustainability sections on their website provide insights into their dedication to this goal.
